Abstract
The underlying pathophysiology of polydipsia in schizophernia is poorly understood. Several studies, however, have suggested that there might be a genetic predisposition to polydipsia. In the present study, using a case-control sample that is independent from the previous family sample, we examined a possible association between polydipsia and functional polymorphisms in the genes of cytochrome P450 (CYP) 1A2 and 2D6, primarily important enzymes to the pharmacokinetics of antipsychotic drugs. Japanese patients with schizophrenia (63 polydipsics and 78 nonpolydipsics) were genotyped for two functional polymorphisms, the 734C/A polymorphism in the CYP1A2 gene and the 2D6*10 allele of the CYP2D6 gene. Neither of the polymorphisms was found to be associated with polydipsia nor was any evidence found that the two polymorphisms have an additive effect on the liability to polydipsia. Our results suggest that the CYP1A2 and CYP2D6 polymorphisms are not likely to play a major role in the development of polydipsia in schizophrenia, although further studies testing other alleles of CYP1A2 and CYP2D6 using different ethnic populations are warranted.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Basile V. S., Ozdemir V., Masellis M., et al. (2000) A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia. Mol. Psychiatry 5, 410–417.
Blum A., Tempey F. W., and Lynch W. J. (1983) Somatic findings in patients with psychogenic polydipsia. J. Clin. Psychiatry 44, 55, 56.
Dahl M. L. (2002) Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing? Clin. Pharmacokinet. 41, 453–470.
de Leon J. (2003) Glucuronidation enzymes, genes and psychiatry. Int. J. Neuropsychopharmacol. 6, 57–72.
de Leon J., Verghese C., Tracy J. I., Josiassen R. C., and Simpson G. M. (1994) Polydipsia and water intoxication in psychiatric patients: a review of the epidemiologicalliterature. Biol. Psychiatry 35, 408–419.
Ferrier I. N. (1985) Water intoxication in patients with psychiatric illness. Br. Med. J. 291, 1594–1596.
Godleski L. S., Vieweg W. V., Barber J. W., Glick J. L., and Yank G. R. (1988) Prevalence of polyuria among chronically psychotic men. Psychiatr. Med. 6, 114–120.
Hoskins R. G. and Sleeper F. H. (1933) Organic functions in schizophrenia. Arch. Neurol. Psychiatry 30, 123–140.
Illowsky B. P. and Kirch D. G. (1988) Polydipsia and hyponatremia in psychiatric patients. Am. J. Psychiatry 145, 675–683.
Johansson I., Oscarson M., Yue Q. Y., et al. (1994) Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Mol. Pharmacol. 46, 452–459.
Matsumoto C., Ohmori O., Shinkai T., Hori H., and Nakamura J. (2004) Genetic association analysis of functional polymorphisms of cytochrome P450 1A2 (CYP1A2) with tardive dyskinesia in Japanese patients with schizophrenia. Psychiatr. Genet. 14, 209–213.
Matsumoto, C., Shinkai T., De Luca, V., et al. (2005) Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia. Int. J. Neuropsychopharmacol. 8, 245–253.
Ohmori O., Suzuki T., Kojima H., et al. (1998) Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics. Schizophr. Res. 32, 107–113.
Sachse C., Brockmoller J., Bauer S., and Roots I. (1997) Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am. J. Hum. Genet. 60, 284–295.
Sachse C., Brockmoller J., Bauer S., and Roots I. (1999) Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br. J. Clin. Pharmacol. 47, 445–449.
Shinkai T., Ohmori O., Hori H., and Nakamura J. (2003) Genetic approaches to polydipsia in schizophrenia: a preliminary report of a family study and an association study of an angiotensin-converting enzyme gene polymorphism. Am. J. Med. Genet. 119B, 7–12.
Silverstein E., Sokoloff L., Mickelesen O., and Jay G. E. Jr. (1958) Polyuria, polydipsia and hydronephrosis in inbred strain of mice. Fed. Proc. 17, 457.
Spears N. M., Leadbetter R. A., and Shutty M. S. Jr. (1996) Clozapine treatment in poly dipsia and intermittent hyponatremia. J. Clin. Psychiatry 57, 123–128.
Staddon S., Arranz M. J., Mancama D., Mata I., and Kerwin R. W. (2002) Clinical applications of pharmacogenetics in psychiatry. Psychopharmacology 162, 18–23.
Suzuki A., Otani K., Mihara K., et al. (1997) Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients. Pharmacogenetics 7, 415–418.
Toru M. (1983) Seishinbunretsubyo no yakuri (Pharmacology in schizophrenia), Chu-gai lyakusha Co., Tokyo.
Van Amelsvoort T., Bakshi R., Devaux C. B., and Schwabe S. (1994) Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia 35, 181–188.
Vieweg W. V., Rowe W. T., David J. J., Curnow R. T., and Spradlin W. W. (1985) Patterns of urinary excretion among patients with self-induced water intoxication and psychosis. Psychiatry Res. 15, 71–79.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsumoto, C., Shinkai, T., De Luca, V. et al. Association study between functional polymorphisms in the cytochrome P450 1A2 and 2D6 genes and polydipsia in schizophrenia. Neuromol Med 8, 381–387 (2006). https://doi.org/10.1385/NMM:8:3:381
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/NMM:8:3:381